Treatment of Polycystic Liver Disease with an Infected Hepatic Cyst

This protocol addresses polycystic liver disease in the specific setting of an infected hepatic cyst — a complication that demands prompt, targeted antimicrobial therapy with careful attention to intracystic drug penetration.

Management centres on antibiotic therapy, with emphasis on selecting an agent — from the fluoroquinolone class — valued for its ability to diffuse effectively into intracystic fluid. Treatment must be sustained; prolonged courses are required. The complete regimen, clinical decision points, and management algorithm are in the full protocol.